Sort   by:  
 Page size 
UnknownTranslational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
Not available
S-EPMC10991874 | biostudies-literature
UnknownTargeting chronic lymphocytic leukemia with B-cell activating factor receptor CAR T cells.
Not available
S-EPMC11366826 | biostudies-literature
UnknownEvaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab.
Not available
S-EPMC5070547 | biostudies-literature
UnknownProgrammed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma.
Not available
S-EPMC5562434 | biostudies-literature
UnknownCancer Mortality Rates Increasing vs Cardiovascular Disease Mortality Decreasing in the World: Future Implications.
Not available
S-EPMC8240359 | biostudies-literature
UnknownRole of radiotherapy in extracranial metastatic malignant melanoma in the modern era.
Not available
S-EPMC5862645 | biostudies-literature
UnknownLow hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors - a major reason for enhanced chemosensitivity?
Not available
S-EPMC5592826 | biostudies-literature
UnknownNCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Not available
S-EPMC5780191 | biostudies-literature
UnknownFive-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Not available
S-EPMC6503622 | biostudies-literature
UnknownUniversal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
Not available
S-EPMC10173369 | biostudies-literature
Sort   by:  
 Page size